GSA Capital Partners’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,101
| Closed | -$219K | – | 1929 |
|
|
2025
Q1 | $219K | Sell |
3,101
-1,460
| -32% | -$103K | 0.02% | 1354 |
|
|
2024
Q4 | $300K | Buy |
4,561
+1,515
| +50% | +$99.6K | 0.02% | 1203 |
|
|
2024
Q3 | $215K | Sell |
3,046
-1,225
| -29% | -$86.5K | 0.02% | 1394 |
|
|
2024
Q2 | $283K | Sell |
4,271
-7,425
| -63% | -$492K | 0.02% | 1303 |
|
|
2024
Q1 | $794K | Buy |
11,696
+4,649
| +66% | +$316K | 0.06% | 602 |
|
|
2023
Q4 | $436K | Buy |
7,047
+2,490
| +55% | +$154K | 0.04% | 886 |
|
|
2023
Q3 | $269K | Buy |
4,557
+435
| +11% | +$25.7K | 0.02% | 1140 |
|
|
2023
Q2 | $246K | Buy |
+4,122
| New | +$246K | 0.02% | 1158 |
|
|
2022
Q1 | – | Sell |
-3,552
| Closed | -$236K | – | 1590 |
|
|
2021
Q4 | $236K | Buy |
3,552
+186
| +6% | +$12.4K | 0.03% | 1108 |
|
|
2021
Q3 | $205K | Buy |
+3,366
| New | +$205K | 0.02% | 1225 |
|